Evidence map›Paper›PMID 35315963›Full record

ArticleBipolar disorders2022

Mental health prior to and during the COVID-19 pandemic in individuals with bipolar disorder: Insights from prospective longitudinal data.

Katie J S Lewis, Katherine Gordon-Smith, Kate E A Saunders, Clare Dolman, Matthew South, John Geddes, Nick Craddock, Arianna Di Florio, Ian Jones, Lisa Jones

Open access · hybridAbstract read
In one paragraph

Article in Bipolar disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Katie J S LewisNational Centre for Mental Health, MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.ORCID 0000-0002-2220-6873
Katherine Gordon-SmithPsychological Medicine, University of Worcester, Worcester, UK.ORCID 0000-0003-4083-1143
Kate E A SaundersDepartment of Psychiatry, Warneford Hospital, Oxford University, Oxford, UK.ORCID 0000-0003-3448-9927
Clare DolmanSection of Women's Mental Health, Institute of Psychiatry, Psychology and Neurosciences, King's College London, London, UK.ORCID 0000-0001-7466-1651
Matthew SouthDepartment of Psychiatry, Warneford Hospital, Oxford University, Oxford, UK.ORCID 0000-0002-3192-5853
John GeddesDepartment of Psychiatry, Warneford Hospital, Oxford University, Oxford, UK.ORCID 0000-0002-5281-5960
Nick CraddockNational Centre for Mental Health, MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.ORCID 0000-0003-2171-0610
Arianna Di FlorioNational Centre for Mental Health, MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.ORCID 0000-0003-0338-2748
Ian JonesNational Centre for Mental Health, MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.ORCID 0000-0001-5821-5889
Lisa JonesPsychological Medicine, University of Worcester, Worcester, UK.ORCID 0000-0002-5122-8334
Centre for Mental Health · GBOxford Health NHS Foundation Trust · GBUniversity of Worcester · GBKing's College London · GB

Funding

Department of Health
6 · The paper itself

Abstract

objectivesMany studies have examined the impact of COVID-19 on the mental health of the public, but few have focused on individuals with existing severe mental illness with longitudinal data before and during the pandemic.

aimsTo investigate the impact of the COVID-19 pandemic on the mental health of people with bipolar disorder (BD).

methodsIn an ongoing study of people with BD who used an online mood monitoring tool, True Colours, 356 participants provided weekly data on their mental health. Symptoms of depression, mania, insomnia, and suicidal thoughts were compared in 2019 and 2020. From May 2020, participants also provided weekly data on the effect of the COVID-19 pandemic on anxiety, coping strategies, access to care, and medications.

resultsOn average, symptoms of depression, mania, insomnia, and suicidal thoughts did not significantly differ in 2020 compared to 2019, but there was evidence of heterogeneity. There were high rates of anxiety about the pandemic and its impact on coping strategies, which increased to over 70% of responders in January 2021. A significant proportion of participants reported difficulty accessing routine care (27%) and medications (21%).

conclusionsAlthough mood symptoms did not significantly increase during the pandemic overall, we observed heterogeneity among our BD sample and other impacted areas. Individuals' unique histories and psychosocial circumstances are key and should be explored in future qualitative studies. The significant impacts of the pandemic may take time to manifest, particularly among those who are socioeconomically disadvantaged, highlighting the need for further long-term prospective studies.

Indexed as

Bipolar DisorderCOVID-19Sleep Initiation and Maintenance DisordersAnxietyDepressionHumansManiaMental HealthPandemicsProspective Studiesbipolar disorderCOVID-19depressionlongitudinalmania

Identifiers

PMID35315963
PMCPMC9111192
OpenAlexW4220885677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.